Not only are people paying way more for drugs these days, pharmaceutical companies are raking it in, with both sales and profit margins reaping the benefits.
Modern Healthcare reports that, according to the Government Accountability Office, people are forking over almost twice as much for prescription drugs as they did 30 years ago. Retail prescription drug expenses ate up some 12 percent of all U.S. healthcare spending in 2015, an increase from the 1990s' 7 percent.
Pharmaceutical and biotechnology sales revenue rose, too, increasing from $534 billion to $775 billion between 2006 and 2015, according to a recent GAO report. And the beneficiaries of all that largesse are the drug companies, with two thirds seeing their profit margins increase by an average of 17.1 percent over that period.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
